Search results
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 10 hours agoThe stock is down more than 30% since Bourla became CEO in January 2019. Pfizer has signaled in...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343(Anti-Claudin18.2 ADC)as...
WFRV 5 Green Bay· 4 hours agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
Cannabis stocks surge on reports DEA will approve rescheduling of marijuana as lower-risk drug
Proactive Investors· 7 days ago“We've written many times how the major reason current multiples are depressed is lack of institutional ownership, this due to a combination of major exchanges ...
Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday
Motley Fool via Yahoo Finance· 6 days agoBut perhaps the most onerous headwind that will be reversed by rescheduling is...companies will no...
Bernie Sanders, 82, Will Seek Another 6-Year Senate Term, Calling His Service 'the Honor of My Life'
People via Yahoo News· 9 hours agoSanders, a third-term senator who previously served eight terms in the House of Representatives,...
The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker...
Zacks via Yahoo Finance· 18 hours agoToday's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC,...
Novo Nordisk, ING, Shell: European Stocks in the Spotlight
The Wall Street Journal· 4 days ago↘️ **Novo Nordisk (DK: NOVO.B**, **NVO)**: Europe's most valuable company raised its annual guidance...
UC Riverside reaches peaceful agreement with student encampment leaders
CBS News· 3 days agoUniversity of California, Riverside administration reached an agreement with leaders of the student...
New York needs comprehensive federal reform for the 340B drug pricing program
Gannett via AOL· 14 hours agoAn important program for many minority and vulnerable communities is the 340B Drug Pricing Program. Federal policymakers created the 340B Program in 1992 to lower the cost ...
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill· 4 days agoDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its...